|
|||
| |||||||||||||||||||||||||||||||||||||||
Dr. Barbara L. Smith (Surgical Oncology): A 56-year-old woman was referred to the multidisciplinary breast clinic, part of the cancer center of this hospital, for management of invasive breast cancer with a minimal tumor burden in a sentinel lymph node.
Four months earlier, screening mammography at another hospital revealed an ill-defined nodule, 0.8 cm in diameter, containing a few calcifications, in the upper outer quadrant of the right breast; the nodule had not been present two years previously. In a follow-up screening, magnification views of the nodule revealed a 1-cm mass in the outer quadrant of the right breast with
Radiological Discussion
Pathological Discussion
Discussion of Management
The Axilla in a Patient with Minimal Disease in the Sentinel Lymph Node
Risk of Additional Nodal Metastases
Risk of Axillary Recurrence
Effect of Axillary Treatment on Survival
Sequelae of Axillary Dissection
Systemic Therapy
Defining the Risk of Recurrence
Efficacy and Toxicity of Adjuvant Systemic Therapy
Anatomical Diagnosis
Source Information
From the Johns Hopkins University School of Medicine, Baltimore (N.E.D.).; the Fox Chase Cancer Center, Philadelphia (M.M.); and the Departments of Radiology (D.B.K.) and Pathology (F.C.K.), Massachusetts General Hospital and Harvard Medical School both in Boston.
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |